233 related articles for article (PubMed ID: 15075268)
21. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.
Pirofski L; Lui R; DeShaw M; Kressel AB; Zhong Z
Infect Immun; 1995 Aug; 63(8):3005-14. PubMed ID: 7622223
[TBL] [Abstract][Full Text] [Related]
22. Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen.
Crawford CJ; Guazzelli L; McConnell SA; McCabe O; d'Errico C; Greengo SD; Wear MP; Jedlicka AE; Casadevall A; Oscarson S
ACS Infect Dis; 2024 Feb; 10(2):475-488. PubMed ID: 37856427
[TBL] [Abstract][Full Text] [Related]
23. Role of the Apt1 protein in polysaccharide secretion by Cryptococcus neoformans.
Rizzo J; Oliveira DL; Joffe LS; Hu G; Gazos-Lopes F; Fonseca FL; Almeida IC; Frases S; Kronstad JW; Rodrigues ML
Eukaryot Cell; 2014 Jun; 13(6):715-26. PubMed ID: 24337112
[TBL] [Abstract][Full Text] [Related]
24. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.
Chang YC; Kwon-Chung KJ
Mol Cell Biol; 1994 Jul; 14(7):4912-9. PubMed ID: 8007987
[TBL] [Abstract][Full Text] [Related]
25. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.
Martinez LR; Moussai D; Casadevall A
Infect Immun; 2004 Jun; 72(6):3674-9. PubMed ID: 15155683
[TBL] [Abstract][Full Text] [Related]
26. Regulated Release of Cryptococcal Polysaccharide Drives Virulence and Suppresses Immune Cell Infiltration into the Central Nervous System.
Denham ST; Verma S; Reynolds RC; Worne CL; Daugherty JM; Lane TE; Brown JCS
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203547
[No Abstract] [Full Text] [Related]
27. Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans.
Liu OW; Kelly MJ; Chow ED; Madhani HD
Eukaryot Cell; 2007 Apr; 6(4):630-40. PubMed ID: 17337638
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule.
Gates-Hollingsworth MA; Kozel TR
Mol Microbiol; 2009 Oct; 74(1):126-138. PubMed ID: 19758241
[TBL] [Abstract][Full Text] [Related]
29. Cas3p belongs to a seven-member family of capsule structure designer proteins.
Moyrand F; Chang YC; Himmelreich U; Kwon-Chung KJ; Janbon G
Eukaryot Cell; 2004 Dec; 3(6):1513-24. PubMed ID: 15590825
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies.
Nakouzi A; Valadon P; Nosanchuk J; Green N; Casadevall A
Infect Immun; 2001 May; 69(5):3398-409. PubMed ID: 11292763
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.
Todaro-Luck F; Reiss E; Cherniak R; Kaufman L
Infect Immun; 1989 Dec; 57(12):3882-7. PubMed ID: 2680986
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies.
Mukherjee J; Kozel TR; Casadevall A
J Immunol; 1998 Oct; 161(7):3557-68. PubMed ID: 9759877
[TBL] [Abstract][Full Text] [Related]
33. Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.
Small JM; Mitchell TG
Infect Immun; 1986 Dec; 54(3):742-50. PubMed ID: 3536747
[TBL] [Abstract][Full Text] [Related]
34. Polysaccharide diversity in VNI isolates of Cryptococcus neoformans from Roraima, Northern Brazil.
Dal Pupo HD; Sena BAG; Reis FCG; Machado L; Fortes ST; de Almeida Junior JN; Godinho RMC; Rodrigues ML
Fungal Biol; 2019 Oct; 123(10):699-708. PubMed ID: 31542188
[TBL] [Abstract][Full Text] [Related]
35. An unusual organelle in Cryptococcus neoformans links luminal pH and capsule biosynthesis.
Yoneda A; Doering TL
Fungal Genet Biol; 2009 Sep; 46(9):682-7. PubMed ID: 19450701
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development.
May RJ; Beenhouwer DO; Scharff MD
J Immunol; 2003 Nov; 171(9):4905-12. PubMed ID: 14568972
[TBL] [Abstract][Full Text] [Related]
37. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction.
McFadden DC; De Jesus M; Casadevall A
J Biol Chem; 2006 Jan; 281(4):1868-75. PubMed ID: 16278213
[TBL] [Abstract][Full Text] [Related]
38. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.
Kozel TR; Levitz SM; Dromer F; Gates MA; Thorkildson P; Janbon G
Infect Immun; 2003 May; 71(5):2868-75. PubMed ID: 12704160
[TBL] [Abstract][Full Text] [Related]
39. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection.
Feldmesser M; Kress Y; Casadevall A
Microbiology (Reading); 2001 Aug; 147(Pt 8):2355-2365. PubMed ID: 11496012
[TBL] [Abstract][Full Text] [Related]
40. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.
Netski D; Kozel TR
Infect Immun; 2002 Jun; 70(6):2812-9. PubMed ID: 12010967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
